20,002 research outputs found
Translational and Regulatory Challenges for Exon Skipping Therapies
Several translational challenges are currently impeding the therapeutic development of antisense-mediated exon skipping approaches for rare diseases. Some of these are inherent to developing therapies for rare diseases, such as small patient numbers and limited information on natural history and interpretation of appropriate clinical outcome measures. Others are inherent to the antisense oligonucleotide (AON)-mediated exon skipping approach, which employs small modified DNA or RNA molecules to manipulate the splicing process. This is a new approach and only limited information is available on long-term safety and toxicity for most AON chemistries. Furthermore, AONs often act in a mutation-specific manner, in which case multiple AONs have to be developed for a single disease. A workshop focusing on preclinical development, trial design, outcome measures, and different forms of marketing authorization was organized by the regulatory models and biochemical outcome measures working groups of Cooperation of Science and Technology Action: "Networking towards clinical application of antisense-mediated exon skipping for rare diseases." The workshop included participants from patient organizations, academia, and members of staff from the European Medicine Agency and Medicine Evaluation Board (the Netherlands). This statement article contains the key outcomes of this meeting.status: publishe
The current state of biomarker research for Friedreich's ataxia: a report from the 2018 FARA biomarker meeting
The 2018 FARA Biomarker Meeting highlighted the current state of development of biomarkers for Friedreich's ataxia. A mass spectroscopy assay to sensitively measure mature frataxin (reduction of which is the root cause of disease) is being developed. Biomarkers to monitor neurological disease progression include imaging, electrophysiological measures and measures of nerve function, which may be measured either in serum and/or through imaging-based technologies. Potential pharmacodynamic biomarkers include metabolic and protein biomarkers and markers of nerve damage. Cardiac imaging and serum biomarkers may reflect cardiac disease progression. Considerable progress has been made in the development of biomarkers for various contexts of use, but further work is needed in terms of larger longitudinal multisite studies, and identification of novel biomarkers for additional use cases
Causal inference for continuous-time processes when covariates are observed only at discrete times
Most of the work on the structural nested model and g-estimation for causal
inference in longitudinal data assumes a discrete-time underlying data
generating process. However, in some observational studies, it is more
reasonable to assume that the data are generated from a continuous-time process
and are only observable at discrete time points. When these circumstances
arise, the sequential randomization assumption in the observed discrete-time
data, which is essential in justifying discrete-time g-estimation, may not be
reasonable. Under a deterministic model, we discuss other useful assumptions
that guarantee the consistency of discrete-time g-estimation. In more general
cases, when those assumptions are violated, we propose a controlling-the-future
method that performs at least as well as g-estimation in most scenarios and
which provides consistent estimation in some cases where g-estimation is
severely inconsistent. We apply the methods discussed in this paper to
simulated data, as well as to a data set collected following a massive flood in
Bangladesh, estimating the effect of diarrhea on children's height. Results
from different methods are compared in both simulation and the real
application.Comment: Published in at http://dx.doi.org/10.1214/10-AOS830 the Annals of
Statistics (http://www.imstat.org/aos/) by the Institute of Mathematical
Statistics (http://www.imstat.org
Family Structure, Substitute Care, and Educational Achievement
Data from the National Longitudinal Survey of Youth are used to explore the educational achievement of youths who lived away from both biological parents for at least four months during childhood. The study focuses on those who spent some time in substitute care (in foster family care, living with relatives, or in institutions), those who left home to be on their own before age 17, and children who were adopted by a couple before age 2. Educational achievement is measured by high school completion, college completion, and highest grade completed by age 25. The 5 to 10 percent of youths in this study who experience surrogate forms of family care on average have lower educational achievement than those who grew up with both biological parents. The educational level of the parents appears to play an important role, and may explain a significant portion of this discrepancy. This study cannot sort out whether the differences in educational achievement reflect the types of youths who enter surrogate forms of care, the reasons for transitions, or the actual substitute care experiences. Its contribution is that it adds analysis of a nationally representative sample of youth to a very thin body of literature on substitute care.
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
INTRODUCTION: The Alzheimer's Disease Neuroimaging Initiative (ADNI) was established in 2004 to facilitate the development of effective treatments for Alzheimer's disease (AD) by validating biomarkers for AD clinical trials.
METHODS: We searched for ADNI publications using established methods.
RESULTS: ADNI has (1) developed standardized biomarkers for use in clinical trial subject selection and as surrogate outcome measures; (2) standardized protocols for use across multiple centers; (3) initiated worldwide ADNI; (4) inspired initiatives investigating traumatic brain injury and post-traumatic stress disorder in military populations, and depression, respectively, as an AD risk factor; (5) acted as a data-sharing model; (6) generated data used in over 600 publications, leading to the identification of novel AD risk alleles, and an understanding of the relationship between biomarkers and AD progression; and (7) inspired other public-private partnerships developing biomarkers for Parkinson's disease and multiple sclerosis.
DISCUSSION: ADNI has made myriad impacts in its first decade. A competitive renewal of the project in 2015 would see the use of newly developed tau imaging ligands, and the continued development of recruitment strategies and outcome measures for clinical trials
Characterizing cardiac involvement in chronic kidney disease using CMR—a systematic review
Purpose of Review:
The aim of the review was to identify and describe recent advances (over the last 3 years) in cardiac magnetic resonance (CMR) imaging in patients with chronic kidney disease (CKD). We conducted a literature review in line with current guidelines.
Recent Findings:
The authors identified 22 studies. Patients with CKD had left ventricular global and regional dysfunction and adverse remodeling. Stress testing with CMR revealed a reduced stress-response in CKD patients. Native T1 relaxation times (as a surrogate markers of fibrosis) are elevated in CKD patients, proportional to disease duration. Patients with CKD have reduced strain magnitudes and reduced aortic distensibility.
Summary:
CMR has diagnostic utility to identify and characterize cardiac involvement in this patient group. A number of papers have described novel findings over the last 3 years, suggesting that CMR has potential to become more widely used in studies in this patient group
Recommended from our members
Multimodal MRI-based Imputation of the Aβ+ in Early Mild Cognitive Impairment.
ObjectiveTo identify brain atrophy from structural-MRI and cerebral blood flow(CBF) patterns from arterial spin labeling perfusion-MRI that are best predictors of the Aβ-burden, measured as composite 18F-AV45-PET uptake, in individuals with early mild cognitive impairment(MCI). Furthermore, to assess the relative importance of imaging modalities in classification of Aβ+/Aβ- early mild cognitive impairment.MethodsSixty-seven ADNI-GO/2 participants with early-MCI were included. Voxel-wise anatomical shape variation measures were computed by estimating the initial diffeomorphic mapping momenta from an unbiased control template. CBF measures normalized to average motor cortex CBF were mapped onto the template space. Using partial least squares regression, we identified the structural and CBF signatures of Aβ after accounting for normal cofounding effects of age, sex, and education.Results18F-AV45-positive early-MCIs could be identified with 83% classification accuracy, 87% positive predictive value, and 84% negative predictive value by multidisciplinary classifiers combining demographics data, ApoE ε4-genotype, and a multimodal MRI-based Aβ score.InterpretationMultimodal-MRI can be used to predict the amyloid status of early-MCI individuals. MRI is a very attractive candidate for the identification of inexpensive and non-invasive surrogate biomarkers of Aβ deposition. Our approach is expected to have value for the identification of individuals likely to be Aβ+ in circumstances where cost or logistical problems prevent Aβ detection using cerebrospinal fluid analysis or Aβ-PET. This can also be used in clinical settings and clinical trials, aiding subject recruitment and evaluation of treatment efficacy. Imputation of the Aβ-positivity status could also complement Aβ-PET by identifying individuals who would benefit the most from this assessment
Investigating the transition from normal driving to safety-critical scenarios
Investigation of the correlation between factors associated with crash development has enabled the implementation of methods aiming to avert and control crash causation at various points within the crash sequence (Evans, 2006). Partitioning the crash sequence is important because intricated crash causation sequences can be deconstructed and effective prevention strategies can be suggested (Wu & Thor, 2015). Towards this purpose, Tingvall et al. (2009) documented the so-called integrated safety chain which described the change of crash risk on the basis of a developing sequence of events that led to a collision. This thesis examines the crash sequence development and thus, the transition from normal driving to safety critical scenarios. [Continues.
- …